MedTrace Logo

Comparison of Oral vs Intravenous Iron Therapy for the Treatment of Postpartum Anemia

NCT07340450 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2026-01-14

No results posted yet for this study

Summary

Postpartum anemia is a common condition associated with adverse maternal outcomes. This study aimed to compare the effectiveness of oral iron therapy versus intravenous iron therapy in women with postpartum anemia.

Conditions

  • Postpartum Anaemia

Interventions

DRUG

Ferric Carboxy Maltose

Participants received Intravenous iron i.e ferric carboxymaltose (≤1,000 mg) were given to patients in Group "A" either as a single dose or as two doses spaced three days apart in 100 milliliters of 0.9% normal saline during a half-hour period.

DRUG

Ferrous Sulfate

Participants given tablet Ferrous sulfate, 325 mg orally three times a day.

Sponsors & Collaborators

  • Shahida Islam Medical Complex

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-18
Primary Completion
2025-08-18
Completion
2025-08-18

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07340450 on ClinicalTrials.gov